Popat S - Search Results

1

Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy.

Felip E, Hirsh V, Popat S, Cobo M, Fülöp A, Dayen C, Trigo JM, Gregg R, Waller CF, Soria JC, Goss GD, Gordon J, Wang B, Palmer M, Ehrnrooth E, Gadgeel SM. Felip E, et al. Among authors: popat s. Clin Lung Cancer. 2018 Jan;19(1):74-83.e11. doi: 10.1016/j.cllc.2017.06.002. Epub 2017 Jun 23. Clin Lung Cancer. 2018. PMID: 28729180 Free article. Clinical Trial.

2

Time and chemotherapy treatment trends in the treatment of elderly patients (age >/=70 years) with small cell lung cancer.

Yau T, Ashley S, Popat S, Norton A, Matakidou A, Coward J, O'Brien ME. Yau T, et al. Among authors: popat s. Br J Cancer. 2006 Jan 16;94(1):18-21. doi: 10.1038/sj.bjc.6602888. Br J Cancer. 2006. PMID: 16317431 Free PMC article.

3

Recurrent responses to non-small cell lung cancer brain metastases with erlotinib.

Popat S, Hughes S, Papadopoulos P, Wilkins A, Moore S, Priest K, Meehan L, Norton A, O'Brien M. Popat S, et al. Lung Cancer. 2007 Apr;56(1):135-7. doi: 10.1016/j.lungcan.2006.11.009. Epub 2006 Dec 8. Lung Cancer. 2007. PMID: 17157952

4

Malignant pleural mesothelioma: two cases in first degree relatives.

Wilkins A, Popat S, Hughes S, O'Brien M. Wilkins A, et al. Among authors: popat s. Lung Cancer. 2007 Sep;57(3):407-9. doi: 10.1016/j.lungcan.2007.02.005. Epub 2007 Apr 2. Lung Cancer. 2007. PMID: 17400330

5

Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survival.

Sirohi B, Ashley S, Norton A, Popat S, Hughes S, Papadopoulos P, Priest K, O'Brien M. Sirohi B, et al. Among authors: popat s. J Thorac Oncol. 2007 Aug;2(8):735-40. doi: 10.1097/JTO.0b013e31811f3a7d. J Thorac Oncol. 2007. PMID: 17762340 Free article.

6

Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancer.

Popat S, Barbachano Y, Ashley S, Norton A, O'Brien M. Popat S, et al. Lung Cancer. 2008 Feb;59(2):227-31. doi: 10.1016/j.lungcan.2007.08.027. Epub 2007 Oct 24. Lung Cancer. 2008. PMID: 17920156

7

Platinum-based chemotherapy in triple-negative breast cancer.

Sirohi B, Arnedos M, Popat S, Ashley S, Nerurkar A, Walsh G, Johnston S, Smith IE. Sirohi B, et al. Among authors: popat s. Ann Oncol. 2008 Nov;19(11):1847-52. doi: 10.1093/annonc/mdn395. Epub 2008 Jun 20. Ann Oncol. 2008. PMID: 18567607 Free article.

8

Treatment options for small cell lung cancer - do we have more choice?

Puglisi M, Dolly S, Faria A, Myerson JS, Popat S, O'Brien ME. Puglisi M, et al. Among authors: popat s. Br J Cancer. 2010 Feb 16;102(4):629-38. doi: 10.1038/sj.bjc.6605527. Epub 2010 Jan 26. Br J Cancer. 2010. PMID: 20104223 Free PMC article. Review.

9

Modest reductions in dose intensity and drug-induced neutropenia have no major impact on survival of patients with non-small cell lung cancer treated with platinum-doublet chemotherapy.

Brunetto AT, Carden CP, Myerson J, Faria AL, Ashley S, Popat S, O'Brien ME. Brunetto AT, et al. Among authors: popat s. J Thorac Oncol. 2010 Sep;5(9):1397-403. doi: 10.1097/JTO.0b013e3181eba7f9. J Thorac Oncol. 2010. PMID: 20644495 Free article.

10

Supersensitive mutation: two case reports of non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.

Myerson JS, Iqbal SA, O'Brien ME, Popat S. Myerson JS, et al. Among authors: popat s. Clin Lung Cancer. 2010 Sep 1;11(5):E5-8. doi: 10.3816/CLC.2010.n.047. Clin Lung Cancer. 2010. PMID: 20837451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

403 results

Search Page